Back to Trials
NCT06789406NARecruiting

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB

Axonics, Inc.

Start Date

9/18/2025

Completion Date

10/1/2031

Summary

Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the Axonics SNM System INS Model 5101.

Detailed Description

This post-market clinical follow-up (PMCF) is conducted to assess the continued safety, device performance, and clinical benefit of the rechargeable Axonics SNM System INS Model 5101 also referred to as R20.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. 18 years or older 2. Primary indication of OAB (urinary urgency incontinence (UUI) / urinary frequency (UF) who are not candidates for, or who have failed conservative treatment 3. Willing and capable to provide written consent and agrees to comply with specified evaluations at clinical centers for all follow-up assessments Exclusion Criteria: 1. Any significant medical condition that is likely to interfere with procedures, device operation, or likely to confound evaluation of endpoints (i.e., neurological conditions such as multiple sclerosis) 2. Any psychiatric or personality disorder that is likely to interfere with procedures at the discretion of the participating physician; this may include poor understanding or compliance with requirements 3. Previously underwent an external sacral neuromodulation SNM trial and was deemed a non-responder or was previously implanted with a sacral neuromodulation device and did not get therapeutic benefit (a non-responder) 4. History of allergic response to titanium, zirconia, polyurethane, epoxy, or silicone 5. A female who is breastfeeding 6. A female with a positive urine pregnancy test

Interventions

DEVICE

Axonics SNM System INS Model 5101 (R20)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Urinary Urge Incontinence (UUI)Urinary Frequency (UF)Overactive Bladder (OAB)

Locations

University of Chicago

Chicago, Illinois 60637

United States

University of Missouri

Columbia, Missouri 65211

United States

Bradford Royal Infirmary

Bradford, West Yorkshire BD96RJ

United Kingdom

Pinderfields Hospital

Wakefield, West Yorkshire WF1 4DG

United Kingdom

University College London Hospital

London, W1G 8PH

United Kingdom